C O M M U N I C A T I O N S
Table 1. Synthesis of Post-Translationally Modified Proteinsa
Scheme 2. MSH-Induced Oxidative Elimination Of Cys Thioethers:
A Functional Switch on Protein Surfaces
its utility in peptide synthesis has not escaped our attention.
Applications to this end, expanded chemistry at Dha, and mecha-
nistic studies are currently under investigation.
Acknowledgment. We gratefully acknowledge FCT, Portugal
(G.J.L.B.) and the Rhodes Trust (J.M.C.) for financial support. We
thank Professor Steven Ley for helpful discussions.
Supporting Information Available: Full experimental details
a See Supporting Information for full details. b Determined by
ESI-MS analysis. c Na+ adduct.
1
including H and 13C NMR data for new compounds and ESI-MS
spectra for all protein modifications. This material is available free of
other hydrophobic polyprene units onto proteins is critical in
membrane localization and protein-protein interactions.20 While
diastereoselectivity of thiol conjugate addition in simple Dha
peptides is typically low,21 the outcome on a protein surface will
be highly dependent on sequence22 and local geometry of the
protein. Furthermore, diastereoselectivity may be inconsequential
when only a reliable, well-defined conjugation strategy is required
or when one modified protein diastereoisomer interacts stereospe-
cifically with enzyme or receptor.
To demonstrate thioether stability, SBL-S-GlcNAc 9 was
subjected to 10 mM glutathione, the natural cellular redox buffer.
Whereas the disulfide counterpart underwent rapid reduction,
thioether 9 exhibited the expected resilience (S23, Supporting
Information).10 This stability, however, does not imply permanence.
The same method for eliminating Cys to Dha was used for
converting such (S)-alkyl cysteine thioethers to Dha; the mechanism
is likely a syn-elimination of the sulfilimine. This strategy was
applied to (S)-ethyl cysteine 16 as well as its protein counterpart
17 (Scheme 2). Regeneration of Dha allows different modifications
in a subsequent step, in this case glycosylation of 7 with GlcNAc-
thiol. This alkyl cysteine nonpermanence is distinguished from other
temporary protein modifications in that it is not due to inherent
reversibility or instability of the linkage, but rather a consequence
of unique reactivity of both cysteine and (S)-alkyl cysteine to MSH.
This “functional switch” allows rapid, controlled conversion
between desired protein modifications.
References
(1) (a) Davis, B. G. Science 2004, 303, 480–482. (b) van Kasteren, S. I.; Kramer,
H. B.; Jensen, H. H.; Campbell, S. J.; Kirkpatrick, J.; Oldham, N. J.; Anthony,
D. C.; Davis, B. G. Nature 2007, 446, 1105–1109. (c) Foley, T. L.; Burkart,
M. D. Curr. Opin. Chem. Biol. 2007, 11, 12–19.
(2) Rich, D. H.; Mathiaparanam, T. P.; Grant, J. A.; Mabuni, C. J. Chem. Soc.,
Chem. Commun. 1974, 897–898.
(3) (a) Hashimoto, K.; Sakai, M.; Okuno, T.; Shirahama, H. Chem. Commun.
1996, 1139–1140. (b) Okeley, N.; Zhu, Y.; van der Donk, W. A. Org. Lett.
2000, 2, 3603–3606.
(4) Seebeck, F. P.; Szostak, J. W J. Am. Chem. Soc. 2006, 128, 7150–7151.
(5) Wang, J.; Schiller, S. M.; Schultz, P. G. Angew. Chem., Int. Ed. 2007, 46,
6849–6851.
(6) Holmes, T. J., Jr.; Lawton, R. G. J. Am. Chem. Soc. 1977, 99, 1984–1986.
(7) (a) Tamura, Y.; Minamikawa, J.; Sumoto, K.; Fujii, S.; Ikeda, M. J. Org. Chem.
1973, 38, 1239–1241. (b) Johnson, C. R.; Kirchhoff, R. A.; Corkins, H. G.
J. Org. Chem. 1974, 39, 2458–2459.
(8) (a) Franek, W.; Claus, P. K. Monatsh. Chem. 1990, 121, 539–547. (b) Matsuo,
J.; Kozai, T.; Ishibashi, H. Org. Lett. 2006, 8, 6095–6098.
(9) Furukawa, N.; Omata, T.; Yoshimura, T.; Aida, T.; Oae, S. Tetrahedron Lett.
1972, 16, 1619–1622.
(10) See Supporting Information for full details.
(11) For sulfilimine conversion to sulfides and sulfoxides, see refs 8b and 9.
(12) DeSantis, G.; Berglund, P.; Stabile, M. R.; Gold, M.; Jones, J. B. Biochemistry
1998, 37, 5968–5973.
(13) In addition to the selective Met recovery shown in Scheme 1, differential
accessibility of C156, M119, M175, and M222 may also play a role.
(14) (a) Hunter, T.; Karin, M. Cell 1992, 70, 375–387. (b) Cohen, P. Nat. Cell
Biol. 2002, 4, E127–E130.
(15) (a) Dwek, R. A. Chem. ReV. 1996, 96, 683–720. (b) Davis, B. G. Chem.
ReV. 2002, 102, 579–601. (c) Ohtsubo, K.; Marth, J. D. Cell 2006, 126,
855–867.
(16) DeSantis, G.; Paech, C.; Jones, J. B. Bioorg. Med. Chem. 2000, 8, 563–570.
(17) (a) Danishefsky, S. J.; Allen, J. A. Angew. Chem., Int. Ed. 2000, 39, 836–
863. (b) Ouerfelli, O.; Warren, J. D.; Wilson, R. M.; Danishefsky, S. J. Exp.
ReV. Vaccines 2005, 4, 677–685. (c) Wittrock, S.; Becker, T.; Kunz, H.
Angew. Chem., Int. Ed. 2007, 46, 5226–5230.
In conclusion, we have presented a new transformation of Cys
to Dha that is useful on protein surfaces. The Dha handle provides
easy access to several important post-translational modifications.
The linkage is stable, yet not permanent, and will likely find wide
use in covalent protein modification. Finally, while the discovery
and development of MSH-mediated conversion of Cys to Dha was
driven by the need for selective methods in protein modification,
(18) Simon, M. D.; Chu, F.; Racki, L. R.; de la Cruz, C. C.; Burlingame, A. L.;
Panning, B.; Narlikar, G. J.; Shokat, K. M. Cell 2007, 128, 1003–1012.
(19) Trojer, P.; Reinberg, D. Cell 2006, 125, 213–217.
(20) (a) Zhang, F. L.; Casey, P. J. Annu. ReV. Biochem. 1996, 65, 241–269. (b)
Marshall, C. J. Science 1993, 259, 1865–1866.
(21) (a) Zhu, Y.; van der Donk, W. A. Org. Lett. 2001, 3, 1189–1192. (b) Galonic,
D. P.; van der Donk, W. A.; Gin, D. Y. Chem.—Eur. J. 2003, 9, 5997–6006.
(22) Schmidt, U.; Öhler, E. Angew. Chem., Int. Ed. Engl. 1976, 15, 42.
JA800800P
9
J. AM. CHEM. SOC. VOL. 130, NO. 15, 2008 5053